igbamedicines.org rapport :   Visitez le site

Données techniques du igbamedicines.org

Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations. Notre service GeoIP a trouvé l'hôte igbamedicines.org.Actuellement, hébergé dans France et son fournisseur de services est OVH SAS .

the related websites

domaine	Titre
igbamedicines.org	international generic and biosimilar medicines association - igba
biogaran.com	biogaran – a pharmaceutical laboratory – generic medicines
homeopathicdoctors.org	homeopathic doctors - alternative holistic medicines
pheur.org	edqm - european directorate for the quality of medicines |
reset.me	reset.me - natural medicines news outlet and community.
onlinepharmacysells.com	home - buy over the counter medicines - online pharmacy sells
swasthyashailee.com	buy ayurvedic and homeopathic medicines online - swasthya shailee
onlinesildenafil.trade	buy sildenafil citrate online. order cheap ed pills, medicines and drugs.
hiv-cure.in	fda approved hiv medicines herbal hiv cure medicine and anti-hiv drugs uganda
atlanticcourier.net	atlantic international express -international courier service, international shi
cialismsnntx.com	generic cialis online
safe-shopping-usa.com	buy levitra generic online
generic-viagra.biz	generic viagra dropshipper
moulinderoquefort.com	usa generic pharmacy. no prescription.
internationalcardsonline.com	international cards - international computer aided research design systems

chu-lyon.fr 

Analyse d'en-tête HTTP

Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé Apache/2.2.34 (Unix) mod_ssl/2.2.34 OpenSSL/1.0.1e-fips DAV/2 PHP/5.4.32 contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.

DNS

HtmlToText

sunday, 04 november 2018 about us | contact aam | cgpa | gbmsa | ipa | japm | jga | medicines for europe | tgpa home about us the igba common igba principles rules of membership contact us photos and video gallery members committees science committee international trade committee intellectual property committee biosimilars committee communication on biosimilar medicines annual igba conference news members events ensuring access to affordable quality medicines worldwide promoting uniform and effective gmp standards and quality controls ensuring timely access for patients members association for accessible medicines canadian generic pharmaceutical association generic & biosimilar medicines southern africa indian pharmaceutical alliance jordanian association of pharmaceutical manufacturers japan generic medicines association medicines for europe taiwan generic pharmaceutical association the igba in an era when increasing demands are being made on the world’s healthcare services, generic and biosimilar medicines provide a major benefit to society by ensuring patient access to quality, safe and effective medicines while reducing the cost of pharmaceutical care. the international generic pharmaceutical alliance (igpa) was founded in march 1997 as an international network of generic medicines associations. the name of the organization was changed in september 2015 to the international generic and biosimilar medicines association (igba) to reflect the evolving nature of the industry. continue reading vision and mission our vision is to promote the widest possible access to generic and biosimilar medicines with high quality, safety and efficacy, support international harmonized pathways for the registration of those medicines, and a strong commitment by members to standards agreed by the international council for harmonization (ich) and who accredited regulators. continue reading news igba reflection paper on waiving bridging studies for biosimilar medicines applications igba proposes a new international biosimilars framework allowing bridging studies to be waived in specific circumstances based on core scientific and regulatory principles established for current products. read more igba position on identification of biological, including biosimilar medicines 2018 update of facts & figures igba position on identification of biological, including biosimilar medicines 2018 update of facts & figures. read more igba submission to hhs blueprint to lower drug prices and reduce out-of-pocket costs [rin 0991-za49] 16th july 2018. in its submission, igba invites the fda to waive the requirement for bridging studies when a foreign-licensed reference comparator product is used for biosimilar development, given that the locally licensed reference product and the foreign-licensed product are … read more access, sustainability and manufacturing competitiveness highlighted at global generic, biosimilar and value added pharmaceutical conference in budapest budapest, 14th june 2018. industry leaders from the generic, biosimilar and value added medicines industries discuss challenges and opportunities in ensuring sustainable, worldwide patient access to pharmaceuticals. medicines for europe and the international generic and biosimilar medicines association (igba) join … read more igba joins ich management committee and welcomes the positive vote of the general assembly tokyo, japan (june 7, 2018) the international generic and biosimilar medicines association (igba) very much welcomes today’s decision of the ich general assembly to elect the igba as an management committee member of the international council for harmonisation of technical … read more igba launches a biosimilar medicines information campaign february 01 2018 - today, the international generic and biosimilar medicines association (igba) launched an information campaign on biosimilar medicines. the foundation of this campaign is the igba biosimilar medicines public slide deck[1]. access to well-referenced information is fundamental to improving … read more igba congratulates the australian government for maintaining their biologics naming convention and for strengthening pharmacovigilance january 29 2018 - the international generic and biosimilar medicines association (igba) welcomes the australian government's decision to maintain the existing naming convention for biological, including biosimilar, medicines, that is to continue using the australian biological name (without a specific identifier … read more 1 2 3 4 5 6 associate members amegi gbma mopi ncpi progenericos mexican association of generic medicines read more generic and biosimilar medicines association (australia) read more malaysian organisation of pharmaceutical industries read more national committee for pharmaceutical industries (saudi arabia) read more brazilian generic medicine drugmakers association read more receive our news in your email account enter your email address: committees read more our members ontwitter tweets de @adefarma/genericos joint 24th medicines for europe and 21st igba annual conference joint 23rd medicines for europe and 20th igba annual conference joint 22nd medicines for europe and 19th igba annual conference contact info igba | international generic and biosimilar medicines association rue d'arlon, 50 b-1000 brussels, belgium telephone: +32 (0)2 736 84 11 fax: +32 (0)2 736 74 38 e-mail: this email address is being protected from spambots. you need javascript enabled to view it. about igba the igba common igba principles rules of membership contact us about us | igba members | committees | conferences | contact us copyright © igba. all rights reserved. - developed by sip we use cookies to improve our website and your experience when using it. cookies used for the essential operation of the site have already been set. to find out more about the cookies we use and how to delete them, see our privacy policy . i accept cookies from this site agree

Analyse PopURL pour igbamedicines.org

https://www.igbamedicines.org/committees/biosimilars-committee/communication-on-biosimilar-medicines
https://www.igbamedicines.org/committees/intellectual-property-committee
https://www.igbamedicines.org/about-us/contact-us
https://www.igbamedicines.org/committees/science-igpa-committee
https://www.igbamedicines.org/news/94-igba-joins-ich-management-committee-and-welcomes-the-positive-vote-of-the-general-assembly
https://www.igbamedicines.org/members/10-members/96-national-committee-for-pharmaceutical-industries
https://www.igbamedicines.org/component/mailto/?tmpl=component&template=wt_churchy&link=38da96187373d1089b8f71049368627bdb910465
https://www.igbamedicines.org/15-news/40-news
https://www.igbamedicines.org/component/mailto/?tmpl=component&template=wt_churchy&link=d0e3d74d819f8b594d4a980c47d49ca117cbb0ba
https://www.igbamedicines.org/news/100-igba-reflection-paper-on-waiving-bridging-studies-for-biosimilar-medicines-applications
https://www.igbamedicines.org/members/10-members/56-mexican-association-of-generic-medicines
https://www.igbamedicines.org/news/93-igba-launches-a-biosimilar-medicines-information-campaign
https://www.igbamedicines.org/committees/international-trade-committee
http://www.igbamedicines.org/members/10-members/82-malaysian-organisation-of-pharmaceutical-industries-mopi
https://www.igbamedicines.org/news/98-igba-submission-to-hhs-blueprint-to-lower-drug-prices-and-reduce-out-of-pocket-costs-rin-0991-za49

Informations Whois

Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;

Domain Name: IGBAMEDICINES.ORG
Registry Domain ID: D177581651-LROR
Registrar WHOIS Server:
Registrar URL: http://www.openprovider.com
Updated Date: 2016-09-16T07:07:01Z
Creation Date: 2015-10-06T13:26:20Z
Registry Expiry Date: 2017-10-06T13:26:20Z
Registrar Registration Expiration Date:
Registrar: Hosting Concepts B.V. d/b/a Openprovider
Registrar IANA ID: 1647
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Reseller:
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Registry Registrant ID: C166900114-LROR
Registrant Name: JOSE ANTONIO GARCIA SANCHEZ
Registrant Organization:
Registrant Street: HOSPITAL DE SAN JOSE 32 - 1 E
Registrant City: GETAFE
Registrant State/Province: MADRID
Registrant Postal Code: 28901
Registrant Country: ES
Registrant Phone: +34.916965032
Registrant Phone Ext:
Registrant Fax:
Registrant Fax Ext:
Registrant Email: jgarcia@sistemas-integrados.com
Registry Admin ID: C166900114-LROR
Admin Name: JOSE ANTONIO GARCIA SANCHEZ
Admin Organization:
Admin Street: HOSPITAL DE SAN JOSE 32 - 1 E
Admin City: GETAFE
Admin State/Province: MADRID
Admin Postal Code: 28901
Admin Country: ES
Admin Phone: +34.916965032
Admin Phone Ext:
Admin Fax:
Admin Fax Ext:
Admin Email: jgarcia@sistemas-integrados.com
Registry Tech ID: C166900114-LROR
Tech Name: JOSE ANTONIO GARCIA SANCHEZ
Tech Organization:
Tech Street: HOSPITAL DE SAN JOSE 32 - 1 E
Tech City: GETAFE
Tech State/Province: MADRID
Tech Postal Code: 28901
Tech Country: ES
Tech Phone: +34.916965032
Tech Phone Ext:
Tech Fax:
Tech Fax Ext:
Tech Email: jgarcia@sistemas-integrados.com
Name Server: NS1SD2716.DNSLINEAGRAFICA.NET
Name Server: NS2SD2716.DNSLINEAGRAFICA.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of WHOIS database: 2017-09-06T13:59:28Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

Access to Public Interest Registry WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the Public Interest Registry registry database. The data in this record is provided by Public Interest Registry for informational purposes only, and Public Interest Registry does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to: (a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator, a Registrar, or Afilias except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. Public Interest Registry reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.

  REFERRER http://www.pir.org/

  REGISTRAR Public Interest Registry

SERVERS

  SERVER org.whois-servers.net

  ARGS igbamedicines.org

  PORT 43

  TYPE domain
RegrInfo
DOMAIN

  NAME igbamedicines.org

  HANDLE D177581651-LROR

  CREATED 2015-06-10

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  NS1SD2716.DNSLINEAGRAFICA.NET 188.165.222.98

  NS2SD2716.DNSLINEAGRAFICA.NET 188.165.222.98

OWNER

  HANDLE C166900114-LROR

  NAME JOSE ANTONIO GARCIA SANCHEZ

ADDRESS

STREET
HOSPITAL DE SAN JOSE 32 - 1 E

  CITY GETAFE

  STATE MADRID

  PCODE 28901

  COUNTRY ES

  PHONE +34.916965032

  EMAIL jgarcia@sistemas-integrados.com

ADMIN

  HANDLE C166900114-LROR

  NAME JOSE ANTONIO GARCIA SANCHEZ

ADDRESS

STREET
HOSPITAL DE SAN JOSE 32 - 1 E

  CITY GETAFE

  STATE MADRID

  PCODE 28901

  COUNTRY ES

  PHONE +34.916965032

  EMAIL jgarcia@sistemas-integrados.com

TECH

  HANDLE C166900114-LROR

  NAME JOSE ANTONIO GARCIA SANCHEZ

ADDRESS

STREET
HOSPITAL DE SAN JOSE 32 - 1 E

  CITY GETAFE

  STATE MADRID

  PCODE 28901

  COUNTRY ES

  PHONE +34.916965032

  EMAIL jgarcia@sistemas-integrados.com

  REGISTERED yes

Erreurs

La liste suivante vous montre les fautes d'orthographe possibles des internautes pour le site Web recherché.